US Equity

Of the two, I prefer Bunge in this space.
The technicals are good, and traders can look at the stock again from the long side.
We are not trimming our sizable oil position in the charitable trust portfolio, but we are also not adding to it.
BABY grew up well, but now we look at risk for a retest of $33.
Sell to Close 1 KBR Jan 15 call and 1 KBR Jan 15 put for a total credit of $5.15 points.
Technicals are bullish, and upcoming earnings could surprise to the upside.
Why chase this low-growth name, near its all-time high, when other quality shares are down 40%?
With so many negative chart signals, the stock has to prove itself and start a bottoming process. It could still go lower.
I could envision a move above $28.50 triggering some playable bullish excitement.
It reports tomorrow, but watch for the company's split. 

Columnist Conversations

There have been no reversal indications aka sell triggers in the SPX against the cycles I was watching. The b...
If you want to make a point about the current action in the FANG stocks you completely undermine any credibili...
Thanks for vote of confidence, but I'm not the market. I just wanted to point out...while you could be right ...
You are brilliant.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.